ARCT
Time to buy ARCT?Arcturus Therapeutics Holdings Inc.
$7.03
+$0.11 (1.56%)Prices delayed. Get real-time quotes here!
2 Days. Real Options Skills.
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatAnalyst Ratings
N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0
Arcturus Therapeutics Holdings Inc. Earnings
We don't currently have information about Arcturus Therapeutics Holdings Inc.'s earnings.